Funded Tech Companies

GenomeDx Biosciences

Wondering who provided funding to GenomeDx Biosciences? Private investors, Merck Global Health Innovation Fund and CD Ventures invested in this biopharmaceutical company.

Company Overview

Company Name
GenomeDx Biosciences
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
1152 Mainland St. 430
Vancouver BC, V6B 4X2
Canada
Email Address

Company Background Information

Overview
GenomeDx is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers.
Profile
GenomeDx Biosciences LinkedIn Company Profile
Social Media
GenomeDx Biosciences Company Twitter Account
Company News
GenomeDx Biosciences News
Facebook
GenomeDx Biosciences on Facebook
YouTube
GenomeDx Biosciences on YouTube
Last Transaction
1/19/2019

Financing History

Date
Type
Amount
Debt
$3,200,000
Venture Equity
$2,675,447
Debt
$4,908,416
Venture Equity
$6,254,241
Venture Equity
$25,385,034
Venture Equity
Unknown
Venture Equity
Unknown


Management Team

Title
Name
Email & Social
Chief Medical Officer
Douglas Dolginow
  Douglas Dolginow LinkedIn Profile  Douglas Dolginow Twitter Account  Douglas Dolginow News  Douglas Dolginow on Facebook
President
Elai Davicioni
  Elai Davicioni LinkedIn Profile  Elai Davicioni Twitter Account  Elai Davicioni News  Elai Davicioni on Facebook
VP - General Counsel
Adam Chinnock
  Adam Chinnock LinkedIn Profile  Adam Chinnock Twitter Account  Adam Chinnock News  Adam Chinnock on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Genome Profiling | GenomeNext

 

Share this article

 


About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary